Impact of Perioperative Opioid Prescriptions on Early and Late Complications After Rhinoplasty: A Propensity-Matched Study

BACKGROUND: Rhinoplasty is one of the most commonly performed facial plastic surgery procedures. Postoperative pain management frequently includes opioid prescriptions, although opioid exposure has been associated with impaired wound healing and increased postoperative complications in several surgical populations. This study aims to evaluate the association between perioperative opioid prescriptions and postoperative complications following rhinoplasty procedures. METHODS: A retrospective cohort study using the TriNetX Research Network identified patients undergoing rhinoplasty between 2005 and 2025 using Current Procedural Terminology codes. Patients were stratified by documented opioid prescriptions within 2 weeks postoperatively. Individuals with prior opioid-related disorders or malignancy were excluded. Outcomes were assessed during early (1-30 d) and late (31-365 d) postoperative intervals. RESULTS: A total of 419,449 rhinoplasty patients were identified, including 312,053 with perioperative opioid exposure and 107,396 controls. After propensity score matching, 85,201 patients remained in each cohort. During the early postoperative period, opioid exposure was associated with higher rates of overall complications (RR 2.11, 95% CI 1.94-2.29, P<0.0001), surgical site complications (RR 1.60, P<0.0001), infection (RR 1.82, P<0.0001), wound disruption (RR 1.53, P=0.0008), emergency department visits or readmissions (RR 2.23, P<0.0001), and mortality (RR 2.08, P<0.0001). During late follow-up, opioid exposure remained associated with higher rates of surgical site complications (RR 1.14, P=0.0049), infection (RR 1.48, P=0.0003), and wound disruption (RR 1.36, P=0.0044). CONCLUSIONS: Perioperative opioid prescriptions were associated with increased postoperative complications following rhinoplasty. These findings support continued efforts to optimize opioid-sparing analgesic strategies in rhinoplasty-related procedures.

Authors

Institutions

Publication Details

Journal
Journal of Craniofacial Surgery
Published
2026-06-29
DOI
https://doi.org/10.1097/scs.0000000000013107
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Perioperative Opioid Prescriptions on Early and Late Complications After Rhinoplasty: A Propensity-Matched Study

Kashyap Komarraju Tadisina, Aneeq S. Chaudhry, Anshumi Desai, A. Scémama et al.
Journal of Craniofacial Surgery
Opioid Use Disorder Treatment
article

Impact of Perioperative Opioid Prescriptions on Early and Late Complications After Rhinoplasty: A Propensity-Matched Study

Kashyap Komarraju Tadisina, Aneeq S. Chaudhry, Anshumi Desai, A. Scémama, Sinan K. Jabori, Katherine Kozlowski, Gabriel De la Cruz-Ku, Devinder P. Singh
article en

Abstract

BACKGROUND: Rhinoplasty is one of the most commonly performed facial plastic surgery procedures. Postoperative pain management frequently includes opioid prescriptions, although opioid exposure has been associated with impaired wound healing and increased postoperative complications in several surgical populations. This study aims to evaluate the association between perioperative opioid prescriptions and postoperative complications following rhinoplasty procedures. METHODS: A retrospective cohort study using the TriNetX Research Network identified patients undergoing rhinoplasty between 2005 and 2025 using Current Procedural Terminology codes. Patients were stratified by documented opioid prescriptions within 2 weeks postoperatively. Individuals with prior opioid-related disorders or malignancy were excluded. Outcomes were assessed during early (1-30 d) and late (31-365 d) postoperative intervals. RESULTS: A total of 419,449 rhinoplasty patients were identified, including 312,053 with perioperative opioid exposure and 107,396 controls. After propensity score matching, 85,201 patients remained in each cohort. During the early postoperative period, opioid exposure was associated with higher rates of overall complications (RR 2.11, 95% CI 1.94-2.29, P<0.0001), surgical site complications (RR 1.60, P<0.0001), infection (RR 1.82, P<0.0001), wound disruption (RR 1.53, P=0.0008), emergency department visits or readmissions (RR 2.23, P<0.0001), and mortality (RR 2.08, P<0.0001). During late follow-up, opioid exposure remained associated with higher rates of surgical site complications (RR 1.14, P=0.0049), infection (RR 1.48, P=0.0003), and wound disruption (RR 1.36, P=0.0044). CONCLUSIONS: Perioperative opioid prescriptions were associated with increased postoperative complications following rhinoplasty. These findings support continued efforts to optimize opioid-sparing analgesic strategies in rhinoplasty-related procedures.

Journal of Craniofacial Surgery
University of Miami (US), Florida International University (US), Universidad Científica del Sur (PE), Temple University Hospital (US), Jacobs Institute (US), University at Buffalo, State University of New York (US), Temple University (US)
Good health and well-being
Openalex Percentile: Top 6%
Opioid Use Disorder Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.